Home » Topics » BioWorld Science

BioWorld Science
RSS

MacroChem completes phase III trial of Topiglan for treatment of ED

July 2, 2001

Mode of action of Oxigene's CA4P supported by preclinical data

July 2, 2001

Newest factor Xa inhibitors and use in thromboembolic disorders reported by DuPont

July 2, 2001

COX-2-selective antiinflammatory, antiphlogistic and analgesic series claimed by Theramex

July 2, 2001

New inhibitors of PDGF receptor autophosphorylation designed at JT

July 2, 2001

Potential of topiramate for diabetes explored using animal models

July 2, 2001

Tetrahydroisoquinolines particularly useful in ADHD according to DuPont

July 2, 2001

Matrix commences new phase II IntraDose study for primary liver cancer

July 2, 2001

Phase III clinical trials of CV Therapeutics' CVT-510 commence

July 2, 2001

Novirio establishes marketing agreement for LdT with Sumitomo

July 2, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...